Australian-New Zealand Clinical Trial: A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of AKV9 in Healthy Adults

Australia, Nov. 10 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of AKV9 in Healthy Adults’. The following are the other relevant details related to the trial:

Trial ID: 392722

Submit Date: 10/13/26 19:00

Study Type: Interventional

Intervention: The proposed study is a 2-part, single-center, randomized, double-blind, placebo-controlled, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of single and multiple ascending doses of AKV9 in approximately 72 healthy adu...